Medical device procurement in Singapore and APAC: a supplier's guide

Singapore is the gateway to APAC medical device procurement. With world-class hospitals, transparent public tendering via GeBIZ, and HSA's regulatory framework that other APAC regulators reference, winning Singapore tenders builds credibility across the region.

But Singapore procurement has rules that differ from Western markets. Here's what medical device suppliers need to know.

HSA registration: the prerequisite

The Health Sciences Authority (HSA) regulates medical devices in Singapore under the Health Products Act. All medical devices must be registered on the Singapore Medical Device Register (SMDR) before they can be sold or tendered.

• Class A: General medical devices — dealer's licence only, no product registration
• Class B: Notification route — 30-day turnaround, relies on reference regulatory approval (FDA, CE, TGA, Health Canada)
• Class C/D: Full registration — clinical evidence review, 6-12 months typical timeline

Key insight: HSA accepts reference approvals from FDA, EU (CE), TGA, and Health Canada. If you already have FDA 510(k) or CE marking, the Singapore registration path is significantly shorter.

GeBIZ: Singapore's public procurement platform

All Singapore government hospital tenders are published on GeBIZ (Government Electronic Business). This includes public hospitals (SGH, NUH, TTSH, CGH, etc.) and polyclinics under the three healthcare clusters (SingHealth, NHG, NUHS).

GeBIZ features:

• All tenders published openly — no invitation-only tenders for standard procurement
• Strict format requirements — responses must be uploaded in the specified template
• Electronic submission with hard deadline enforcement — the portal closes automatically
• Evaluation criteria published upfront (technical merit + price)

How Singapore tenders differ from Western markets

Price weight is higher: Singapore public hospital tenders typically weight price at 30-40% (vs. 20-30% in EU). Technical merit still matters, but pricing competitiveness is more decisive.

Past performance matters: References from Singapore hospitals carry significant weight. First-time entrants face a credibility gap that must be overcome with strong technical submissions and regional references (Malaysia, Thailand, Hong Kong).

Delivery and service: Singapore has zero tolerance for delivery delays. Service response time commitments (typically 4-hour response, 24-hour resolution for critical equipment) are contractual obligations, not aspirational targets.

Local representation: Most tenders require a local authorized distributor or subsidiary. Direct cross-border tendering is rare for medical devices.

Expanding from Singapore to APAC

Singapore tender wins create leverage across APAC:

• Malaysia: MDA (Medical Device Authority) accepts Singapore HSA registration as reference. Many Malaysian hospitals look to Singapore purchasing decisions as benchmarks.
• Thailand: Thai FDA has its own registration process but Singapore references strengthen applications. Bangkok's private hospital market is large and growing.
• Indonesia: BPOM registration required. Large public hospital market but longer procurement cycles and more relationship-driven decisions.
• Philippines: FDA Philippines registration needed. Public hospital tenders via PhilGEPS. Growing market with increasing device sophistication.
• Vietnam: Ministry of Health registration. Rapidly growing market with new hospital construction driving device procurement.

Winning strategy for APAC tenders

The suppliers that win consistently in APAC share four traits:

1. Multi-market registration: HSA + TGA + at least two other APAC regulatory approvals
2. Regional service infrastructure: Local service engineers, not fly-in support from headquarters
3. Competitive pricing: APAC markets are more price-sensitive than EU/US — build this into your pricing strategy
4. Fast, complete tender responses: GeBIZ deadlines are enforced. Automated tender response is the difference between responding to 5 tenders/month and 15.